Radiotherapy can activate club cells in the lungs, releasing proteins beneficial for immunotherapy, effectively inhibiting MDSCs and reducing pro-cancer inflammation in the TME, ultimately enhancing anti-tumor immune responses and PD-1 inhibitor efficacy (198). The gene discussed is PDCD1; the disease is neoplasm.